Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil
Carregando...
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
CARDOSO, Maria Regina Alves
PEREIRA, Wendry Maria Paixao
PEREIRA, Elaine Cristina
REZENDE, Debora Aparecida Paccola de
GUARIZI, Rubia Guibo
DELLU, Mayra Cecilia
OLIVEIRA, Jessica de Moura
FLAUZINO, Erika
Citação
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, v.20, n.4, p.470-476, 2013
Resumo
Objective: The aims of this study were to estimate the prevalence of metabolic syndrome among women aged 35 to 65 years and to identify associated factors. Methods: This was a cross-sectional study. We randomly selected 581 women (aged 35-65 y) from among those enrolled in a family health program in the city of Pindamonhangaba, Brazil. Metabolic syndrome was identified in accordance with the definition of the National Cholesterol Education Program Adult Treatment Panel III. Health conditions and lifestyle habits were evaluated by a survey, and anthropometric measurements were obtained. The prevalence of metabolic syndrome was estimated, and Poisson regression was used to evaluate the associations between metabolic syndrome 'and the factors investigated. Results: The prevalence of metabolic syndrome was 42.2% (95% CI, 38.1-46.2). The most common metabolic syndrome component was abdominal obesity (60.6%), followed by low levels of high-density lipoprotein cholesterol (51.3%), high levels of triglycerides (41.4%), high blood pressure (31.7%), and diabetes (13.9%). The following factors were associated with metabolic syndrome: the 45- to 54-year age group (prevalence ratio, 1.54; 95% CI, 1.08-2.01), the 55- to 65-year age group (prevalence ratio, 3.51; 95% CI, 1.49-3.10), hyperuricemia (prevalence ratio, 2.95; 95% CI, 1.15-1.86), and sleep apnea risk (prevalence ratio, 2.41; 95% CI, 1.16-1.82). We found an inverse association between metabolic syndrome and having had more than 5 years of schooling (prevalence ratio, 0.65; 95% CI, 0.65-1.04). Conclusions: The prevalence of metabolic syndrome is high, and the associated clinical factors are hyperuricemia and risk of sleep apnea.
Palavras-chave
Metabolic syndrome, Prevalence, Premenopause, Postmenopause
Referências
- Aguilar-Salinas CA, 2004, ARCH MED RES, V35, P76, DOI 10.1016/j.arcmed.2003.06.006
- Alam I, 2007, OBES REV, V8, P119, DOI 10.1111/j.1467-789X.2006.00269.x
- Almeida GPL, 2004, REV SOC CARDIOL ESTA, V14, P630
- Berg G, 2004, HORM METAB RES, V36, P215
- Block G, 2000, AM J PREV MED, V18, P284, DOI 10.1016/S0749-3797(00)00119-7
- Bompadre MC, 2007, REV ASOC MED ARGENT, V120, P8
- Brasil Ministerio da Saude, 2002, POL NAC AT INT HIP A
- Brasil Ministerio da Saude, SIST INF AT BAS
- Brasil Ministerio da Saude, 2006, PACT GEST SUS
- British Hypertension Society, VAL BLOOD PRESS MON
- Brown TM, 2008, J WOMENS HEALTH, V17, P841, DOI 10.1089/jwh.2007.0536
- BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4
- Castro-Costa E, 2008, ADDICT BEHAV, V33, P1598, DOI 10.1016/j.addbeh.2008.07.004
- Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
- Desroches S, 2007, APPL PHYSIOL NUTR ME, V32, P23, DOI 10.1139/H06-095
- Drapeau V, 2007, OBES SURG, V17, P905, DOI 10.1007/s11695-007-9168-1
- Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
- Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016
- Fernandez-Berges D, 2011, GAC SANIT, V25, P519, DOI 10.1016/j.gaceta.2011.05.009
- Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
- Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575
- Ford ES, 2004, ENDOCRIN METAB CLIN, V33, P333, DOI 10.1016/j.ecl.2004.03.004
- Gigliotti Analice, 2005, Rev Bras Psiquiatr, V27, P37, DOI 10.1590/S1516-44462005000100010
- Gronner MF, 2012, BRAZ J MED BIOL RES, V44, P713
- Gruber A, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-22
- Instituto Brasileiro de Geografia e Estatistica, 2005, PESQ NAC AM DOM SINT
- JOHNS MW, 1991, SLEEP, V14, P540
- Kaduka LU, 2012, DIABETES CARE, V35, P887, DOI 10.2337/dc11-0537
- KANNEL WB, 1976, ANN INTERN MED, V85, P447
- Kawada Tomoyuki, 2008, Metabolic Syndrome and Related Disorders, V6, P137, DOI 10.1089/met.2008.0011
- Lee HJ, 2011, GYNECOL ENDOCRINOL, V27, P406, DOI 10.3109/09513590.2010.493962
- Lopes HF, 2004, REV SOC CARDIOL ESTA, V14, P539
- Martinez MA, 2008, METABOLISM, V57, P1232, DOI 10.1016/j.metabol.2008.04.017
- Menon VU, 2008, NATL MED J INDIA, V21, P112
- Morales DD, 2008, DIABETES VASC DIS RE, V5, P36, DOI 10.3132/dvdr.2008.007
- Nakazone MA, 2007, REV ASSOC MED BRAS, V53, P407, DOI 10.1590/S0104-42302007000500016
- Netzer NC, 1999, ANN INTERN MED, V131, P485
- Oliveira EP, 2006, ARQ BRAS ENDOCRINOL, V50, P456
- Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032
- Pimenta AM, 2011, CIENC SAUDE COLETIVA, V16, P3297, DOI 10.1590/S1413-81232011000800029
- Qader SS, 2008, CLIMACTERIC, V11, P475, DOI 10.1080/13697130802451787
- Raimundo M, 2011, CARDIOL RES PRACT, V2011, P1, DOI 10.4061/2011/747861
- Riediger ND, 2011, CAN MED ASSOC J, V183, pE1127, DOI 10.1503/cmaj.110070
- Royer M, 2007, CLIMACTERIC, V10, P164, DOI 10.1080/13697130701258895
- Salaroli LB, 2007, ARQ BRAS ENDOCRINOL, V51, P1143, DOI 10.1590/S0004-27302007000700018
- Schnell Mercedes, 2007, An Venez Nutr, V20, P92
- Scuteri Angelo, 2003, J Clin Hypertens (Greenwich), V5, P219, DOI 10.1111/j.1524-6175.2003.00683.x
- Suarez AL, 2008, REV ESP CARDIOL, V61, P1150
- [Anonymous], 1988, CONST REP FED BRAS
- [Anonymous], 2001, JAMA, V285, P2486